LUGANO-SINGAPORE, 23 October 2020 - The ESMO Asia Congress 2020, the leading scientific platform in the Asia-Pacific region, will be held as a virtual meeting. (1)
The Scientific Programme will cover sub-group analysis on patients of Asian ethnicity in latest phase III trials, providing evidence of benefit from new therapies in the most prevalent cancer types in the region. (2)
Programme highlights:
Programme details and abstract titles are available online. (3) Please kindly note that session timings are in local Singapore time (SGT).
ESMO welcomes media interested in reporting from the ESMO events and on cancer issues. Only through the official accreditation process with the ESMO Media Registration Form, accredited media representatives will be able to access embargoed material and the Congress webcast. (4)
###
Further information
ESMO Press Office
media@esmo.org
Notes to Editors
Please make sure to use the official name of the meeting in your reports: ESMO Asia Virtual Congress 2020
Official Hashtag: #ESMOAsia20
References
(1) ESMO Asia Virtual Congress 2020 https://www.esmo.org/meetings/esmo-asia-2020-virtual
(2) Scientific Programme https://cslide.ctimeetingtech.com/asia2020/attendee/confcal/session/calendar
(3) Programme details and abstract titles https://cslide.ctimeetingtech.com/asia2020/attendee/confcal/session/calendar
(4) Media Registration Form https://esmo.formstack.com/forms/media_registration_form_asia2020
About the European Society for Medical Oncology (ESMO)
ESMO is the leading professional organisation for medical oncology. With more than 25,000 members representing oncology professionals from over 160 countries worldwide, ESMO is the society of reference for oncology education and information. ESMO is committed to offer the best care to people with cancer, through fostering integrated cancer care, supporting oncologists in their professional development, and advocating for sustainable cancer care worldwide. http://www.esmo.org